These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9718074

  • 1. Hyperforin as a possible antidepressant component of hypericum extracts.
    Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE.
    Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
    [Abstract] [Full Text] [Related]

  • 2. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
    Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():16-21. PubMed ID: 9684943
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.
    Chatterjee SS, Nöldner M, Koch E, Erdelmeier C.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():7-15. PubMed ID: 9684942
    [Abstract] [Full Text] [Related]

  • 4. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W, Schober F, Mannel M.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [Abstract] [Full Text] [Related]

  • 5. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
    Bhattacharya SK, Chakrabarti A, Chatterjee SS.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():22-9. PubMed ID: 9684944
    [Abstract] [Full Text] [Related]

  • 6. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M, Moia M, Pirona L, Morizzoni P, Mennini T.
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M, Singer A, Siebert B, Müller WE.
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [Abstract] [Full Text] [Related]

  • 8. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H.
    Life Sci; 2003 Jun 20; 73(5):627-39. PubMed ID: 12770617
    [Abstract] [Full Text] [Related]

  • 9. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G, Schüle C, Baghai T, Kieser M.
    Pharmacopsychiatry; 1998 Jun 20; 31 Suppl 1():54-9. PubMed ID: 9684948
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
    Wonnemann M, Singer A, Müller WE.
    Neuropsychopharmacology; 2000 Aug 20; 23(2):188-97. PubMed ID: 10882845
    [Abstract] [Full Text] [Related]

  • 11. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 20; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of MAO by fractions and constituents of hypericum extract.
    Bladt S, Wagner H.
    J Geriatr Psychiatry Neurol; 1994 Oct 20; 7 Suppl 1():S57-9. PubMed ID: 7857511
    [Abstract] [Full Text] [Related]

  • 13. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P.
    CNS Drug Rev; 2004 Oct 20; 10(3):203-18. PubMed ID: 15492771
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
    Schellenberg R, Sauer S, Dimpfel W.
    Pharmacopsychiatry; 1998 Jun 20; 31 Suppl 1():44-53. PubMed ID: 9684947
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R, Borrelli F, Capasso F, Mascolo N, Izzo AA.
    Urology; 2004 Jul 20; 64(1):168-72. PubMed ID: 15245964
    [Abstract] [Full Text] [Related]

  • 16. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A, Lorrain E.
    Encephale; 2014 Apr 20; 40(2):108-13. PubMed ID: 23816060
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS.
    J Pharmacol Exp Ther; 2000 Jul 20; 294(1):88-95. PubMed ID: 10871299
    [Abstract] [Full Text] [Related]

  • 18. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity.
    Jensen AG, Hansen SH, Nielsen EO.
    Life Sci; 2001 Feb 23; 68(14):1593-605. PubMed ID: 11263672
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V.
    CNS Drugs; 2003 Feb 23; 17(8):539-62. PubMed ID: 12775192
    [Abstract] [Full Text] [Related]

  • 20. Hyperforin--antidepressant activity by a novel mechanism of action.
    Müller WE, Singer A, Wonnemann M.
    Pharmacopsychiatry; 2001 Jul 23; 34 Suppl 1():S98-102. PubMed ID: 11518085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.